At a glance
- Originator Kissei Pharmaceutical
- Class Antihypertensives; Dipeptides; Heart failure therapies
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension